These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The Food and Drug Administration and patent law at a crossroads: the listing of polymorph patents as a barrier to generic drug entry. Srivastava D Food Drug Law J; 2004; 59(2):339-54. PubMed ID: 15298015 [No Abstract] [Full Text] [Related]
25. Between a rock and a hard place. Demaria AN J Am Coll Cardiol; 2010 Nov; 56(21):1761-2. PubMed ID: 21070930 [No Abstract] [Full Text] [Related]
26. The FDA's accelerated approval process: does the pharmaceutical industry have adequate incentives for self-regulation? Orlando VI Am J Law Med; 1999; 25(4):543-68. PubMed ID: 10629734 [No Abstract] [Full Text] [Related]
27. Moment of reckoning. Wadman M Nature; 2007 Apr; 446(7138):844-5. PubMed ID: 17443154 [No Abstract] [Full Text] [Related]
28. Off-label drug use. Dooley AG Med Health R I; 2007 Feb; 90(2):63-5. PubMed ID: 17500258 [No Abstract] [Full Text] [Related]
29. Competitors try collaboration to speed drug development. Patlak M J Natl Cancer Inst; 2010 Jun; 102(12):841-3. PubMed ID: 20530762 [No Abstract] [Full Text] [Related]
30. The fast track effect. Cohen FJ Nat Rev Drug Discov; 2004 Apr; 3(4):293-4. PubMed ID: 15124622 [No Abstract] [Full Text] [Related]
31. Accelerated approval and oncology drug development timelines. Lanthier ML; Sridhara R; Johnson JR; Farrell A; Keegan P; Justice R; Pazdur R J Clin Oncol; 2010 May; 28(14):e226-7; author reply e228. PubMed ID: 20194846 [No Abstract] [Full Text] [Related]
32. FDA notifications. New pediatric guidelines by NIH, CDC. AIDS Alert; 2009 Oct; 24(10):117-8. PubMed ID: 20034139 [No Abstract] [Full Text] [Related]
33. Cancer drug approval in the United States, Europe, and Japan. Milsted RA Adv Cancer Res; 2007; 96():371-91. PubMed ID: 17161686 [No Abstract] [Full Text] [Related]
34. Impact of new regulations for pediatric labeling by the Food and Drug Administration. Buck ML Pediatr Nurs; 2000; 26(1):95-6. PubMed ID: 12026326 [No Abstract] [Full Text] [Related]
35. Re: Clinical trials registration efforts gain some ground. Manrow RE J Natl Cancer Inst; 2005 Jun; 97(12):936. PubMed ID: 15956658 [No Abstract] [Full Text] [Related]
36. The FDA and "privatization"--the drug approval process. Rutherford EM Food Drug Law J; 1995; 50 Spec():203-25. PubMed ID: 10343044 [No Abstract] [Full Text] [Related]
37. Progress and deficiencies in the registration of clinical trials. Wood AJ N Engl J Med; 2009 Feb; 360(8):824-30. PubMed ID: 19228628 [No Abstract] [Full Text] [Related]